Ibex Investors’s Insulet PODD Stock Holding History

Ibex Investors’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,758	Closed	-$263K	–	252
2017 Q4	$263K	Buy	+3,758	New	+$247K	0.15%	108

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ibex Investors's PODD Position: Q1 2018 in Review

Ibex Investors sold out of Insulet (PODD) in Q1 2018, closing a stake of 3,758 shares — an estimated $263K sold.

Ibex Investors first reported a position in PODD in Q4 2017 and held it in 1 quarter. The position peaked at $263K in Q4 2017. 214 funds tracked by Wall St. Rank hold PODD as of Q1 2018.

Ibex Investors reported no remaining Insulet position as of Q1 2018 after selling out during the quarter.
Ibex Investors sold 3,758 Insulet shares in Q1 2018, an estimated $263K.
Ibex Investors first reported a position in Insulet in Q4 2017 and held it in 1 quarter.
Ibex Investors's Insulet position peaked at $263K in Q4 2017.
214 funds tracked by Wall St. Rank held Insulet as of Q1 2018.

Based on Ibex Investors's 13F filing for Q1 2018, filed 15 May 2018.